---
title: "Zaleplon - Disorders Of Initiating And Maintaining Sleep"
sidebar: mydoc_sidebar
permalink: db00962-mesh-d007319-1.html
toc: false 
---


Path ID: `DB00962_MESH_D007319_1`
{% include image.html url="images/db00962-mesh-d007319-1.png" file="db00962-mesh-d007319-1.png" alt="db00962-mesh-d007319-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C085665 | zaleplon | Drug |
| UniProt:P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | Protein |
| GO:0005237 | inhibitory extracellular ligand-gated ion channel activity | MolecularActivity |
| HP:0002360 | Sleep disturbance | PhenotypicFeature |
| MESH:D007319 | Disorders of initiating and maintaining sleep | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Zaleplon | POSITIVELY REGULATES | Gamma-Aminobutyric Acid Receptor Subunit Alpha-1 |
| Gamma-Aminobutyric Acid Receptor Subunit Alpha-1 | POSITIVELY REGULATES | Inhibitory Extracellular Ligand-Gated Ion Channel Activity |
| Inhibitory Extracellular Ligand-Gated Ion Channel Activity | NEGATIVELY CORRELATED WITH | Sleep Disturbance |
| Sleep Disturbance | CORRELATED WITH | Disorders Of Initiating And Maintaining Sleep |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00962](https://go.drugbank.com/drugs/DB00962)
  - [https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020859s013lbl.pdf](https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020859s013lbl.pdf)
